MMI-0100 structure
|
Common Name | MMI-0100 | ||
|---|---|---|---|---|
| CAS Number | 1039342-24-9 | Molecular Weight | 2283.64 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C98H171N37O26 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MMI-0100MMI-0100 is a cell-permeant peptide inhibitor of mitogen activated protein kinase activated protein kinase II (MK2). MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. MMI-0100 suppresses IL-6 expression without effect on IL-8 expression. MMI-0100 suppresses fibrotic processes such as vein graft disease[1]. |
| Name | MMI-0100 |
|---|
| Description | MMI-0100 is a cell-permeant peptide inhibitor of mitogen activated protein kinase activated protein kinase II (MK2). MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. MMI-0100 suppresses IL-6 expression without effect on IL-8 expression. MMI-0100 suppresses fibrotic processes such as vein graft disease[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C98H171N37O26 |
|---|---|
| Molecular Weight | 2283.64 |